US Health Authorities: AZ Clinical Results May Include Outdated Information

[Image source=Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has raised suspicions that outdated information may have been included in the results of a large-scale clinical trial conducted by AstraZeneca (AZ) in the United States.

On the 23rd (local time), NIAID stated this at the U.S. Drug Safety Monitoring Board (DSMB) and expressed "concerns."

The DSMB also conveyed these suspicions to AstraZeneca and the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

The issue raised by U.S. health authorities concerns the additional clinical trial results announced by AstraZeneca on the 21st.

AstraZeneca revealed that in an additional clinical trial conducted on over 30,000 people in the U.S., the effectiveness of its COVID-19 vaccine was shown to be 79%.

This content was produced with the assistance of AI translation services.